ArticlePatient preference and adherence2023

Palbociclib Adherence and Persistence in Patients with Hormone Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer.

Nicole M Engel-Nitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.